High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease.
Thirty-eight patients with previously treated Hodgkin's disease were given high dose combination chemotherapy using melphalan and BCNU and autologous bone marrow transplantation. In 25 patients etoposide was added in conventional dosage. During the course of the study the dose of melphalan was...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Nature Publishing Group
1989
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247129/ |